Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 3/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | GHSR | Q92847 | 2/20 | 0.32 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.31 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19511225 | 0.88 | AR (0.36) | CYP1A2MTNR1AARALDH1A1LMNA | |
| SCHEMBL19511212 | 0.84 | AR (0.35) | MTNR1AARALDH1A1 | |
| SCHEMBL19511293 | 0.81 | AR (0.33) | AR | |
| SCHEMBL19511941 | 0.78 | PRKCG (0.35) | AR | |
| SCHEMBL19511452 | 0.74 | SRC (0.35) | SRC | |
| SCHEMBL19056880 | 0.73 | SLC40A1 (0.39) | KDM4ELMNATP53GAAMAPT | |
| SCHEMBL19056871 | 0.72 | CCR1 (0.35) | ALDH1A1LMNAHTT | |
| SCHEMBL19056884 | 0.71 | PARP1 (0.32) | PARP1 | |
| SCHEMBL19511770 | 0.71 | SRC (0.46) | KDM4EALDH1A1LMNATP53GAA | |
| SCHEMBL19511342 | 0.71 | SRC (0.33) | ARSRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3239156-B1 | NOVEL GROUP 4 TRANSITION METAL COMPOUND AND USE OF SAME | HANWHA CHEMICAL CORP (KR) | 2023-03-01 | — | — | EP | disclosed |
| CN-107001500-B | Novel group 4 transition metal compound and use thereof | 韩华化学株式会社 | 2020-11-03 | — | — | CN | disclosed |
| US-10364302-B2 | Group 4 transition metal compound and use thereof | HANWHA CHEMICAL CORPORATION (KR) | 2019-07-30 | — | — | US | disclosed |
| US-20180002461-A1 | NOVEL GROUP 4 TRANSITION METAL COMPOUND AND USE THEREOF | HANWHA CHEMICAL CORPORATION (KR) | 2018-01-04 | — | — | US | disclosed |
| EP-3239156-A1 | NOVEL GROUP 4 TRANSITION METAL COMPOUND AND USE OF SAME | Hanwha Chemical Corporation (KR) | 2017-11-01 | — | — | EP | disclosed |
| CN-107001500-A | The 4th novel group transition metal compound and application thereof | 韩华化学株式会社 | 2017-08-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180002461-A1 | NOVEL GROUP 4 TRANSITION METAL COMPOUND AND USE THEREOF | MORF4L1, TRPV4, TRPM4 | PARP1 183/4885CYP1A2 1562/4885GHSR 4871/4885 |
| US-10364302-B2 | Group 4 transition metal compound and use thereof | TRPM4, MORF4L1, TRPV4 | PARP1 217/4885CYP1A2 1702/4885GHSR 4863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.